Ryan J Cornelius1, Jinge Si1, Catherina A Cuevas1, Jonathan W Nelson1, Brittany D K Gratreak1, Ruggero Pardi2, Chao-Ling Yang1, David H Ellison3,4. 1. Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon. 2. School of Medicine and Scientific Institute, San Raffaele University, Milan, Italy; and. 3. Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon; ellisond@ohsu.edu. 4. Renal Section, Veterans Affairs Portland Health Care System, Portland, Oregon.
Abstract
BACKGROUND: The familial hyperkalemic hypertension (FHHt) cullin 3 (CUL3) mutant does not degrade WNK kinases normally, thereby leading to thiazide-sensitive Na-Cl cotransporter (NCC) activation. CUL3 mutant (CUL3Δ9) does not bind normally to the COP9 signalosome (CSN), a deneddylase involved in regulating cullin-RING ligases. CUL3Δ9 also caused increased degradation of the CUL3-WNK substrate adaptor kelch-like 3 (KLHL3). Here, we sought to determine how defective CSN action contributes to the CUL3Δ9 phenotype. METHODS: The Pax8/LC1 mouse system was used to generate mice in which the catalytically active CSN subunit, Jab1, was deleted only along the nephron, after full development (KS-Jab1 -/-). RESULTS: Western blot analysis demonstrated that Jab1 deletion increased the abundance of neddylated CUL3. Moreover, total CUL3 expression was reduced, suggesting decreased CUL3 stability. KLHL3 was almost completely absent in KS-Jab1 -/- mice. Conversely, the protein abundances of WNK1, WNK4, and SPAK kinases were substantially higher. Activation of WNK4, SPAK, and OSR1 was indicated by higher phosphorylated protein levels and translocation of the proteins into puncta, as observed by immunofluorescence. The ratio of phosphorylated NCC to total NCC was also higher. Surprisingly, NCC protein abundance was low, likely contributing to hypokalemia and Na+ and K+ wasting. Additionally, long-term Jab1 deletion resulted in kidney damage. CONCLUSIONS: Together, the results indicate that deficient CSN binding contributes importantly to the FHHt phenotype. Although defective CUL3Δ9-faciliated WNK4 degradation likely contributes, dominant effects on KLHL3 may be a second factor that is necessary for the phenotype.
BACKGROUND: The familial hyperkalemic hypertension (FHHt) cullin 3 (CUL3) mutant does not degrade WNK kinases normally, thereby leading to thiazide-sensitive Na-Cl cotransporter (NCC) activation. CUL3 mutant (CUL3Δ9) does not bind normally to the COP9 signalosome (CSN), a deneddylase involved in regulating cullin-RING ligases. CUL3Δ9 also caused increased degradation of the CUL3-WNK substrate adaptor kelch-like 3 (KLHL3). Here, we sought to determine how defective CSN action contributes to the CUL3Δ9 phenotype. METHODS: The Pax8/LC1mouse system was used to generate mice in which the catalytically active CSN subunit, Jab1, was deleted only along the nephron, after full development (KS-Jab1 -/-). RESULTS: Western blot analysis demonstrated that Jab1 deletion increased the abundance of neddylated CUL3. Moreover, total CUL3 expression was reduced, suggesting decreased CUL3 stability. KLHL3 was almost completely absent in KS-Jab1 -/- mice. Conversely, the protein abundances of WNK1, WNK4, and SPAK kinases were substantially higher. Activation of WNK4, SPAK, and OSR1 was indicated by higher phosphorylated protein levels and translocation of the proteins into puncta, as observed by immunofluorescence. The ratio of phosphorylated NCC to total NCC was also higher. Surprisingly, NCC protein abundance was low, likely contributing to hypokalemia and Na+ and K+ wasting. Additionally, long-term Jab1 deletion resulted in kidney damage. CONCLUSIONS: Together, the results indicate that deficient CSN binding contributes importantly to the FHHt phenotype. Although defective CUL3Δ9-faciliated WNK4 degradation likely contributes, dominant effects on KLHL3 may be a second factor that is necessary for the phenotype.
Authors: Huabo Su; Jie Li; Suchithra Menon; Jinbao Liu; Asangi R Kumarapeli; Ning Wei; Xuejun Wang Journal: Circ Res Date: 2010-11-04 Impact factor: 17.367
Authors: Turgay Saritas; Aljona Borschewski; James A McCormick; Alexander Paliege; Christin Dathe; Shinichi Uchida; Andrew Terker; Nina Himmerkus; Markus Bleich; Sylvie Demaretz; Kamel Laghmani; Eric Delpire; David H Ellison; Sebastian Bachmann; Kerim Mutig Journal: J Am Soc Nephrol Date: 2013-02-07 Impact factor: 10.121
Authors: Mohammed Z Ferdaus; Lauren N Miller; Larry N Agbor; Turgay Saritas; Jeffrey D Singer; Curt D Sigmund; James A McCormick Journal: JCI Insight Date: 2017-12-21
Authors: Michelle O'Reilly; Elaine Marshall; Thomas Macgillivray; Manish Mittal; Wei Xue; Chris J Kenyon; Roger W Brown Journal: J Am Soc Nephrol Date: 2006-08-09 Impact factor: 10.121
Authors: Anita Schlierf; Eva Altmann; Jean Quancard; Anne B Jefferson; René Assenberg; Martin Renatus; Matthew Jones; Ulrich Hassiepen; Michael Schaefer; Michael Kiffe; Andreas Weiss; Christian Wiesmann; Richard Sedrani; Jörg Eder; Bruno Martoglio Journal: Nat Commun Date: 2016-10-24 Impact factor: 14.919
Authors: Ryan J Cornelius; Mohammed Z Ferdaus; Jonathan W Nelson; James A McCormick Journal: Curr Opin Nephrol Hypertens Date: 2019-09 Impact factor: 2.894
Authors: Harish E Chatrathi; Jason C Collins; Lynne A Wolfe; Thomas C Markello; David R Adams; William A Gahl; Achim Werner; Prashant Sharma Journal: Hypertension Date: 2021-12-02 Impact factor: 10.190
Authors: Yujiro Maeoka; Mohammed Z Ferdaus; Ryan J Cornelius; Avika Sharma; Xiao-Tong Su; Lauren N Miller; Joshua A Robertson; Susan B Gurley; Chao-Ling Yang; David H Ellison; James A McCormick Journal: J Am Soc Nephrol Date: 2022-01-21 Impact factor: 14.978
Authors: Zhenan Liu; Joonho Yoon; Chonlarat Wichaidit; Ankita B Jaykumar; Hashem A Dbouk; Addie E Embry; Liping Liu; Joel M Henderson; Audrey N Chang; Melanie H Cobb; Richard Tyler Miller Journal: Front Cell Dev Biol Date: 2021-02-02